Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection
Lin Yao, Guolin Wang, Yuan Shen, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 4, pp. 586-594
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, et al.
Cell Reports (2021) Vol. 36, Iss. 6, pp. 109518-109518
Open Access | Times Cited: 199
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi, Pilar Alcaide, Folkert W. Asselbergs, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 336-356
Open Access | Times Cited: 122
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu, Meiyu Wang, Xiao‐Ai Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 101
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 14
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Gregory Milne, Thomas Hames, Chris J. Scotton, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1450-1466
Open Access | Times Cited: 78
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Haya Altawalah
Vaccines (2021) Vol. 9, Iss. 8, pp. 910-910
Open Access | Times Cited: 69
Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
Kosuke Okuya, Takanari Hattori, Takeshi Saito, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 42
Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
Hari Ram Choudhary, Debaprasad Parai, Girish Chandra Dash, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 41
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
T-CELL IMMUNE RESPONSE TO SARS-COV-2 IN HEALTHCARE WORKERS 2.5-3 YEARS AFTER COVID-19
И. Д. Решетникова, Yury A. Tyurin, Р. С. Фассахов, et al.
Russian Journal of Allergy (2025)
Closed Access
COVID-19 reinfection: the role of natural immunity, vaccines, and variants
Bao Y. Sciscent, Caroline Eisele, Lisa Ho, et al.
Journal of Community Hospital Internal Medicine Perspectives (2021) Vol. 11, Iss. 6, pp. 733-739
Open Access | Times Cited: 33
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study
Willem A. Mak, Johannes G.M. Koeleman, Marijke van der Vliet, et al.
Journal of Infection (2021) Vol. 84, Iss. 2, pp. 171-178
Open Access | Times Cited: 33
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
Dominik Menges, Kyra D. Zens, Tala Ballouz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection
Andrea Boccatonda, Elena Campello, Chiara Simion, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 14
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 19
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection
Gabriel Siracusano, Chiara Brombin, Claudia Pastori, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
Anna Solastie, Camilla Virta, Anu Haveri, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 23
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
Pyoeng Gyun Choe, Chang Kyung Kang, Kye‐Hyung Kim, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 6, pp. 1097-1099
Open Access | Times Cited: 22
Regression Models for Understanding COVID-19 Epidemic Dynamics With Incomplete Data
Corbin Quick, Rounak Dey, Xihong Lin
Journal of the American Statistical Association (2021) Vol. 116, Iss. 536, pp. 1561-1577
Open Access | Times Cited: 22
Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis
Qiu Li, Lu Chen, Fen Li, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection
Stefan Glöckner, Franziska Hornung, Michael Baier, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 2003-2003
Open Access | Times Cited: 18
Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
Michael J. Peluso, Joanna Donatelli, Timothy J. Henrich
Translational research (2021) Vol. 241, pp. 1-12
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top